Cold & Cough Remedies - GCC

GCC

Highlights

In the GCC, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$431.00m.
It is projected to experience an annual growth rate of 5.30% (CAGR 2024-2029).
Among other countries worldwide, the United States generates the highest revenue in this market, amounting to US$11.19bn in 2024.
When considering the total population, per person revenues reach US$7.14 in 2024.
The demand for cold & cough remedies in the GCC market is driven by the region's high prevalence of respiratory conditions and the desire for quick relief.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Cold & Cough Remedies market in GCC is experiencing steady growth due to increasing customer preferences for over-the-counter remedies and the rising incidence of respiratory illnesses. Customer preferences in the GCC region have shifted towards self-medication and home remedies, leading to an increased demand for over-the-counter Cold & Cough Remedies. Consumers are seeking convenience and cost-effectiveness, and are more inclined to purchase these remedies without a prescription. This trend is driven by the busy lifestyles of individuals in the region who prefer quick and accessible solutions for their health issues. Furthermore, the GCC region has a high prevalence of respiratory illnesses such as cold and cough, which has contributed to the growth of the Cold & Cough Remedies market. Factors such as extreme weather conditions, air pollution, and the presence of large expatriate populations in the region have increased the risk of respiratory illnesses. As a result, individuals are actively seeking remedies to alleviate symptoms and recover quickly. In addition to customer preferences, there are several trends in the Cold & Cough Remedies market in the GCC region. One notable trend is the increasing adoption of natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of synthetic medications and are turning to natural alternatives. This trend is driven by the perception that natural remedies are safer and have fewer adverse effects. As a result, manufacturers are introducing a wide range of natural and herbal Cold & Cough Remedies to cater to this growing demand. Another trend in the market is the emphasis on product innovation and differentiation. With the increasing competition in the market, manufacturers are focusing on developing unique formulations and delivery formats to stand out from their competitors. This includes the introduction of innovative packaging, such as single-dose sachets and convenient sprays, as well as the incorporation of additional ingredients to enhance the effectiveness of the remedies. These innovations not only attract customers but also provide added value and convenience. Local special circumstances in the GCC region also contribute to the development of the Cold & Cough Remedies market. The region has a high disposable income due to its oil-rich economy, enabling consumers to afford and purchase these remedies. Additionally, the GCC countries have a well-developed healthcare infrastructure, which includes a wide network of pharmacies and retail outlets where these remedies are readily available. This accessibility further drives the growth of the market. Underlying macroeconomic factors such as population growth, urbanization, and increasing healthcare expenditure also play a role in the development of the Cold & Cough Remedies market in the GCC region. As the population continues to grow and urbanization increases, the demand for healthcare products, including Cold & Cough Remedies, is expected to rise. Moreover, the governments in the GCC region are investing heavily in healthcare infrastructure and services, which will further support the growth of the market. Overall, the Cold & Cough Remedies market in the GCC region is growing due to customer preferences for over-the-counter remedies, the high prevalence of respiratory illnesses, and various market trends. The market is further supported by local special circumstances and underlying macroeconomic factors, which contribute to the increasing demand for these remedies in the region.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.